Trial intelligence / Profile preview

Phase II randomized double-blind placebo-controlled trial of Baoxin Granules for chronic heart failure

CTR20212336Phase 2Completed

Sponsor
Institute of Chinese Materia Medica
Start
Oct 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Baoxin Granules in chronic heart failure (CHF), sponsored by Institute of Chinese Materia Medica. Started Oct 2021; status: completed.

02

Drugs

Baoxin Granules
03

Conditions

chronic heart failure (CHF)

Beyond the preview

Go deeper on CTR20212336.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20212336.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call